Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 290

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer

Open access
Gao, Yaohui, Bi, Dexi, Xie, Ruting, Li, Man, Guo, Jing, Liu, Hu, Guo, Xianling, Fang, Juemin, Ding, Tingting, Zhu, Huiyuan, Cao, Yuan, Xing, Meichun, Zheng, Jiayi, Xu, Qing, Xu, Qian, Wei, Qing, Qin, Huanlong·2021·Signal Transduction and Targeted Therapy

Abstract

Given that only a subset of patients with colorectal cancer (CRC) benefit from immune checkpoint therapy, efforts are ongoing to identify markers that predict immunotherapeutic response. Increasing evidence suggests that microbes influence the efficacy of cancer therapies. Fusobacterium nucleatum induces different immune responses in CRC with different microsatellite-instability (MSI) statuses. Here, we investigated the effect of F. nucleatum on anti-PD-L1 therapy in CRC. We found that high F. nucleatum levels correlate with improved therapeutic responses to PD-1 blockade in patients with CRC. Additionally, F. nucleatum enhanced the antitumor effects of PD-L1 blockade on CRC in mice and prolonged survival. Combining F. nucleatum supplementation with immunotherapy rescued the therapeutic effects of PD-L1 blockade. Furthermore, F. nucleatum induced PD-L1 expression by activating STING signaling and increased the accumulation of interferon-gamma (IFN-γ)+ CD8+ tumor-infiltrating lymphocytes (TILs) during treatment with PD-L1 blockade, thereby augmenting tumor sensitivity to PD-L1 blockade. Finally, patient-derived organoid models demonstrated that increased F. nucleatum levels correlated with an improved therapeutic response to PD-L1 blockade. These findings suggest that F. nucleatum may modulate immune checkpoint therapy for CRC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41392-021-00795-x

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 290

Metadata

Authors
Gao, Y., Bi, D., Xie, R., Li, M., Guo, J., Liu, H., Guo, X., Fang, J., Ding, T., Zhu, H., Cao, Y., Xing, M., Zheng, J., Xu, Q., Xu, Q., Wei, Q., & Qin, H.
Venue
Signal Transduction and Targeted Therapy
Published
2021-11-19
Volume
6
Issue
1
Pages
398-398
ISSN
2059-3635 (ISSN-L)
OpenAlex
W3213342404
Cited by
290
References
37
FWCI
12.64
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer. https://app.cochat.ai/papers/10.1038/s41392-021-00795-x
The paper
Gao, Y., Bi, D., Xie, R., Li, M., Guo, J., Liu, H., Guo, X., Fang, J., Ding, T., Zhu, H., Cao, Y., Xing, M., Zheng, J., Xu, Q., Xu, Q., Wei, Q., & Qin, H. (2021). Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-021-00795-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.